Rare diseases
Investigational molecules
Locations
703 conditions with trials, the busiest first
3 898 trials across Europe, recruiting first
Study of 18F-FAPI-74 PET/CT Imaging for Detection of Lymph Node Metastases in Patients with Colon Cancer
FinlandStudy of 64Cu-DOTATATE and 18F-FDG PET/CT imaging to predict disease progression in patients with neuroendocrine neoplasms
DenmarkStudy on Acalabrutinib, Obinutuzumab, and Venetoclax for Untreated High-Risk Chronic Lymphocytic Leukemia Patients
AustriaStudy on the Effectiveness of Tepotinib and Drug Combination for Patients with Advanced Cancer
NorwayStudy on the Safety and Effectiveness of HDP-101 for Patients with Relapsed or Refractory Multiple Myeloma
GermanyStudy of Linvoseltamab in Adults with Relapsed or Refractory Multiple Myeloma
BelgiumStudy on Letrozole Maintenance Therapy for Patients with Epithelial Ovarian Cancer
AustriaStudy on the Effectiveness of Yttrium-90 Microspheres and Capecitabine for Patients with Operable Intrahepatic Cholangiocarcinoma
FranceStudy on F-18 PSMA-11 PET Imaging for Liver Cancer in Patients to Evaluate Survival
BelgiumLong-term safety study of Temferon (modified stem cells with interferon-α2) in patients previously treated for glioblastoma multiforme
ItalyStudy of Gilteritinib, Venetoclax, and Azacitidine for Patients with Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutations Not Eligible for Intensive Treatment
GermanyStudy on Crizotinib for Treating Severe Neurofibromatosis Type 2 in Children Not Eligible for Surgery or Radiotherapy
PolandThe therapies tested most often in Neoplasms benign, malignant and unspecified (incl cysts and polyps) trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
